April 2022 Issue Contents
Dry eye device therapies staged for a comeback
April 30, 2022 | Olympic Ophthalmics and Oyster Point are pursuing neuromodulation therapies despite Allergan’s device exit.
Closed-loop VNS for heart failure has untapped potential
Startup firm Ceryx Medical is using respiratory sinus arrhthmia as a key input in their system.
New indications loom large for bioelectronic medicine
Two industry veterans and an NIH representative offered advice on finding new opportunities.
Bioelectronic medicine investors discuss outlook in NYC
A panel of venture capital professionals discussed the funding outlook at the Bioelectronic Medicine Forum.
Axonics announces commercial launch of F15 SNM system
The new primary cell device complements the company’s rechargeable system.
News in brief
News updates from Medtronic and Nyxoah.
